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Background: Preoperative evaluation with contrast-enhanced multidetector computed tomographic angiography (MDCTA) is considered an 
“appropriate” indication based on expert criteria. There is, however, little published data to support this recommendation. We aimed to evaluate the 
impact of pre-surgical MDCTA on perioperative outcomes and cost of reoperative cardiac surgery (RCS).
Methods: We studied 364 patients undergoing RCS from 2004 to 2008, including 137 referred for MDCTA. The primary endpoint was the 
composite of perioperative death, myocardial infarction (MI), stroke, and hemorrhage-related reoperation. Secondary endpoints included surgical 
procedural variables, volume of perioperative bleeding, and amount of red blood cell (RBC) transfusion. Additionally, a detailed analysis of the billing 
charge records was performed to evaluate for potential cost differences.
Results: Baseline clinical characteristics were similar between the 2 groups. Individuals referred for MDCTA showed a trend toward a lower 
incidence of the composite primary endpoint (17.5% vs. 24.2%; p=0.13), primarily related to a significantly lower incidence of perioperative MI (0% 
vs. 5.7%, p=0.002). MDCTA was also significantly associated with shorter perfusion time (90 vs. 110 min, p=0.002), cross clamp time (63 vs. 75 
min, p=0.003), total time in the intensive care unit (103 vs. 148 hrs, p=0.04), and a lower volume of postoperative RBC transfusion (627 vs. 824 cc, 
p=0.09). These differences remained significant after adjustment for the STS score and performing surgeon. An analysis of hospital charges showed 
a trend toward overall cost savings ($163,000 vs. $192,000, p=0.06) associated with preoperative cardiac MDCTA, driven in part by significant 
savings in nursing care ($8,803 vs. $13,400, p=0.002) and postoperative intensive care costs ($2,741 vs. $4,636, p <0.001).
Conclusions: The use of MDCTA prior to RCS was associated with shorter perfusion and cross clamp times; shorter intensive care unit stays, less 
frequent perioperative MI, and lower charges in some postoperative care elements.
